Related Experiment Video
Updated: Feb 12, 2026

Techniques to Induce and Quantify Cellular Senescence
Published on: May 1, 2017
Down-regulation of cancer-associated gene CDC73 contributes to cellular senescence
Qi Jia1, Hongbo Nie1, Xuechao Wan2
1Ministry of Education Key Laboratory of Contemporary Anthropology, Collaborative Innovation Center of Genetics and Development, School of Life Sciences and Huashan Hospital, Fudan University, Shanghai, 200438, China.
Abstract:
Dysregulated gene expression is another important contributor in explaining cancer-related phenotypes in addition to mutations. Cellular senescence is a mechanism for the prevention of cancer and thus it is important to understand the regulation of gene expression in senescence due to its potential in anti-cancer therapy. Here, we found that CDC73, which encodes the cell division cycle 73 and acts as a tumor suppressor, was unexpectedly up-regulated in several cancer types but down-regulated in a variety of senescent cells. Importantly, depletion of CDC73 could induce senescence-associated phenotypes in both normal and cancer cells, with an increase in p21 expression. In terms of molecular mechanism, alternative polyadenylation (APA)-mediated 3' untranslated region (3' UTR) lengthening explained, at least in part, the decreased CDC73 expression in senescent cells because longer 3' UTR had a higher rate of RNA degradation compared to the shorter one. Our work discovered that post-transcriptional down-regulation of CDC73 contributed to cellular senescence.
Insights
Cell division cycle 73 (CDC73) is down-regulated in senescent cells, promoting cancer prevention. This post-transcriptional regulation, via alternative polyadenylation, offers potential anti-cancer therapy strategies.
Area of Science:
- Molecular Biology
- Cancer Research
- Cellular Biology
Background:
- Gene expression dysregulation contributes to cancer phenotypes beyond mutations.
- Cellular senescence is a crucial tumor-preventive mechanism.
- Understanding gene expression regulation in senescence is key for anti-cancer therapies.
Purpose of the Study:
- Investigate the role of CDC73 in cellular senescence and cancer.
- Elucidate the molecular mechanisms behind CDC73 dysregulation in senescence.
- Explore the therapeutic potential of targeting CDC73 in cancer.
Main Methods:
- Analysis of CDC73 expression in cancer types and senescent cells.
- Depletion of CDC73 in normal and cancer cells to assess senescence induction.
- Investigation of alternative polyadenylation (APA) and 3' UTR length in CDC73 regulation.
Main Results:
- CDC73 was unexpectedly up-regulated in cancers but down-regulated in senescent cells.
- CDC73 depletion induced senescence-associated phenotypes and increased p21 expression.
- APA-mediated 3' UTR lengthening contributed to decreased CDC73 expression in senescent cells.
Conclusions:
- Post-transcriptional down-regulation of CDC73 is a significant factor in cellular senescence.
- CDC73's role in senescence suggests its potential as a therapeutic target for cancer.
- Alternative polyadenylation is a key mechanism controlling CDC73 expression during senescence.
Related Concept Videos
Gene Regulation During Sporulation
Circadian Rhythms and Gene Regulation
Constitutive and Regulated Gene Expression
Master Transcription Regulators
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

